This activity is supported by an educational grant from Merck & Co., Inc.0.50 CME 0.50 ABIM MOC 30 MINS $0 FEE
This continuing medical education activity is provided by :
This activity is supported by an educational grant from Merck & Co., Inc.
Chronic cough, which is observed in approximately 12% of the US population, is defined as a cough that lasts for more than 8 weeks. Patients with chronic cough are often distressed by the condition, which can lead to depression, anxiety, a decline in quality of life, and changes to their social activities. The diagnosis and management of chronic cough can be challenging, with only approximately 50% of patients receiving a diagnosis. Recent advances have been made in the understanding and management of refractory chronic cough, with several novel therapies being evaluated in ongoing clinical studies. In this educational activity, a multidisciplinary expert panel will review the burden of chronic cough, discuss the current recommendations for the management of patients with chronic cough, and evaluate the latest clinical data regarding emerging pharmacotherapies for the treatment of patients with refractory chronic cough.